Hirneiss C, Kampik A, Neubauer A S
Augenklinik der Ludwig-Maximilians-Universität, München, Deutschland.
Ophthalmologe. 2010 Mar;107(3):223-7. doi: 10.1007/s00347-009-2035-9.
The application of value-based medicine (VBM) tenets in the area of glaucoma research requires valid and reliable data concerning the quality of life with glaucoma. A multitude of instruments for measuring quality of life of patients with glaucoma have been employed in the past. Any instrument used would need to capture peripheral vision loss and its influence on patient-reported quality of life as this is one of the hallmarks of this disease. Cost-utility analyses can then be based on the reported quality of life and the cost of glaucoma therapy. Several cost-utility analyses have been applied in the field of glaucoma screening as well as treating ocular hypertension and based on this a recommendation regarding population subgroups which can be treated cost efficiently can be made.
在青光眼研究领域应用基于价值的医学（VBM）原则需要有关青光眼患者生活质量的有效且可靠的数据。过去已采用了多种用于测量青光眼患者生活质量的工具。所使用的任何工具都需要捕捉周边视力丧失及其对患者报告的生活质量的影响，因为这是该疾病的特征之一。然后，成本效用分析可以基于所报告的生活质量和青光眼治疗的成本。在青光眼筛查以及治疗眼压升高领域已经应用了一些成本效用分析，并据此可以对能够以成本效益方式进行治疗的人群亚组提出建议。
